Jubilant Ingrevia - Strong Growth Outlook: HDFC Securities Retail Research Initiates Coverage
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
HDFC Securities Retail Research Report
Jubilant Ingrevia Ltd. has presence across mainly three segments specialty chemicals (33% of revenue), nutrition and health solutions (18%) and life science chemicals (49%), with strong backward integration and a leading market position.
About 25% of life science chemicals volumes and 45% of pyridine and picolines (speciality chemicals) are consumed in house, leading to retaining of higher profit across the value chain.
During FY21, the company derived about 54% of its revenue through exports and deemed exports.
The company has a diversified customer base with the top 10 customers accounting 20-25% of total revenue.
Jubilant Ingrevia has 60 plus products in pipeline across its business segment.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.